European Journal of Medicinal Chemistry p. 89 - 94 (2014)
Update date:2022-08-15
Topics:
Guo, Xiaoke
Ma, Xianglei
Yang, Qian
Xu, Jing
Huang, Lu
Jia, Jianmin
Shan, Jiaojiao
Liu, Li
Chen, Weilin
Chu, Hongxi
Wei, Jinlian
Zhang, Xiaojin
Sun, Haopeng
Tang, Yiqun
You, Qidong
Kv1.5 potassium channel is an efficacious and safe therapeutic target for the treatment of atrial fibrillation (AF), the most common arrhythmia that threatens human. Herein, by modifying the hit compound 7k from an in-house database, 48 derivatives were synthesized for the assay of their Kv1.5 inhibitory effects by whole cell patch clamp technique. Six compounds which showed better potency than the positive compound dronedarone were selected for the next evaluation of their drug-like properties. Compound 8 exhibited balanced solubility and permeability. It also showed acceptable pharmacodynamics profile with very low acute toxicity. Taking all these data into account, compound 8 can serve as a promising lead for the development of novel therapeutic agent for the treatment of AF.
View MoreBaoding City Light Industry And Textiles Imp.& Exp. Corp. Chemical Department.
Contact:86-312-3262436
Address:NO.658 CHAOYANG SOUTH STREET,BAODING CITY HEBEI CHINA
suzhou chukai pharmateach co,.ltd
Contact:86-512-88812511
Address:Building 3, Wujiang Scientific Innovation Park, 2358 Changan Rd, Wujiang 215200, Jiangsu Province, P. R. China
Contact:+86-519-86623222
Address:29F/D, 99 Yanling West Road, Changzhou, Jiangsu, China
website:http://www.debyesci.com
Contact:+85221376140
Address:Rm. 19C, Lockhart Ctr., 301-307 Lockhart Rd., Wan Chai
Taizhou Crene Biotechnology co.ltd
Contact:86-576-88813233 88205808
Address:Economic Developed Zone of Taizhou Zhejiang China
Doi:10.1016/S0040-4020(01)93032-7
(1970)Doi:10.1016/j.tetlet.2013.02.046
(2013)Doi:10.1021/acs.joc.5b02251
(2015)Doi:10.3390/molecules18021963
(2013)Doi:10.1002/hc.21058
(2013)Doi:10.1021/acs.orglett.7b00793
(2017)